access all movies

Updates

20
Sep 14

What Is The Message Being Sent Here?


I just finished reading Gene Ross’ article about the Manson Parody (?p=4855) and then I saw the article about the Blade Runner Parody (?p=4870).  Now I must voice my opinion on these porn parodies, it’s not just that it seems like producers are desperate for ideas, it’s the message they are sending that bothers me!  It seems to me that the adult industry is sending the message that it’s alright to kill women, as long as you fuck them first.  Is this really the message we want to be sending people to their bedrooms with?  I think this is just a disgrace and it makes the adult industry look even worse than it does already!

I have an issue with the adult industry glorifying murderers because they had hot sex before they killed people.  Come on y’all, seriously?! How can you ignore the fact that both of these stories ended cold blooded murder?  Ignorance is not bliss, these people that were slain had families and this is a slap in the face to them in my opinion!

If this is what gets you off, then maybe it’s time you seek some professional help!!

15
Sep 14

Talent Testing Services Answered My Question…..


In response to my question, what do you do with the plasma once it is spun off in the centrifuge so the blood can be tested/screened?, TTS provided me with this answer:

Dear Ms. Peters,

The samples are discarded. Unless proper consent has been obtained or proper delinking (completely anonymizing the samples) procedures are in place, samples may not be used for any other purpose.
That is good to hear!  I have yet to hear back from CET but I did email them the same question I sent to TTS.  I also emailed CET to let them know the issue I have with them using the HIV 1 PCR Quantitative assay to confirm a false positive, no response there either!
14
Sep 14

How To Confirm False Positive…Or How Not To Rather!


Apparently with the last one day moratorium they were able to confirm a false positive and get back to shooting safely after only one day off, this never added up to me! How can they be sure it was a flase positive after only one day? when on their own website the FSC  states: Performers must wait 14 days from the last sexual contact with the positive performer before retesting.

So, I decided to ask James Deen of APAC to assist me with comprehending this timeline and here is his response:

their main issue on this is that they referred to this as a moratorium when it was not.  this was a 2 day confirmatory hold on production.  they are able to verify that it was a false positive because within the 14 days prior to this she had a negative test.  so…

day 1 – negative test

day 14 – positive test

day 14/15/16 – negative test

the 14 day incubation period has already occurred.  them calling production hold at the first sight of a possible hiv was something apac fought hard for.  they certainly should not have called it a moratorium

To recap August 28, 2014 FSC calls moratorium due to positive HIV test and August 29, 2014 calls moratorium off because they confirmed the false positive.  So, I had to ask just how does the FSC and Cutting Edge Testing confirm the false positive?  After many inquiries I found out that CET uses the HIV 1 PCR Quantitative test to confirm false positives in the adult industry.

There are  two HIV1 RNA PCR Quantitative tests on the market, Abbott m2000 and Roche COBAS TaqMan.  Cutting Edge Testing states that they use the Roche COBAS AmpliPrep/COBAS Taqman HIV test and goes on to say that it’s FDA approved for detection of HIV-1 RNA Viral load. So, I did my homework on both tests and found the following:

From: https://www.abbottmolecular.com/us/products/infectious-diseases/realtime-pcr/hiv-1-assay.html

INTENDED USE

The Abbott RealTime HIV-1 assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of Human Immunodeficiency Virus type 1 (HIV-1) on the automated m2000 System in human plasma from HIV-1 infected individuals over the range of 40 to 10,000,000 copies/mL. The Abbott RealTime HIV-1 assay is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels. This assay is not intended to be used as a donor screening test for HIV-1 or as a diagnostic test to confirm the presence of HIV-1 infection.

From: http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/PremarketapprovalsPMAs/ucm09287.pdf

INTENDED USE

The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test is an in vitro nucleic acid amplification test for the quantitation of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in human plasma using the COBAS® AmpliPrep Instrument for automated specimen processing and COBAS® TaqMan® Analyzer or COBAS® TaqMan® 48 Analyzer for automated amplification and detection.

This test is intended for use in conjunction with clinical presentation and other laboratory markers of dis­ ease progress for the clinical management of HIV-1 infected patients. The Test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level or to monitor the effects of antiretroviral therapy by measuring changes in EDTA plasma HIV-1 RNA levels during the course of antiretroviral treatment.

The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test is not intended for use as a screening test for the presence of HIV-1 in blood or blood products or as a diagnostic test to confirm the presence of HIV-1 infection.

In conclusion, I have some serious issues with the way performer health and safety has been handled by the FSC up to this point.  Performers need to be more aware of what risks they are taking and better informed about what methods are being used because,”the latest cutting-edge testing” isn’t enough information for anyone to make an informed decision.  It’s time that performers are educated about STDs and HIV.  There should be some literature made available to performers about how to identify an STD, how to prevent transmission of STDs and vaccinations, and where to get free or inexpensive treatment for STDs! Keeping performers in the dark is hurting the entire industry, and now with all the escorting going on (male and female),hurting the general public!

Please note that Talent Testing Services did give me a different answer than CET & FSC and agreed that the HIV RNA Quantitative assay test is used in patient management in order to determine viral load in already diagnosed cases.  TTS states that they use an algorithm in order to discard any possibility of false positives including, but not limited to, repeating the test with a different sample.

Maybe the adult industry needs to have a standard of testing that is the same across the board and has full disclosure to all performers about the types of testing being performed, after all it is the performers’ health on the line here!

THE ADULT INDUSTRY NEEDS BETTER HEALTH AND SAFETY PRACTICES AND BETTER ON SET PROTOCOL. I consider myself to be the unofficial spokesperson for this change and I am not giving up or going away! I am not getting paid for my time and effort; I am doing it because I actually care and someone has to stand up for performer rights! I am not getting paid off by some foundation or production company to tell you false truths… like so many others! I urge you all to be more aware of what you’re getting yourself into and stand up for your right to work in a safe work environment! Don’t get pressured into taking risks for monetary gain because the treatment and time off work will cost you more in the long run! 

 

13
Sep 14

Did Anyone Bother To Pay Attention?


Did anyone bother to notice that when I pointed out that APHSS (Adult Performer Health and Safety Services) was screening performers for HIV and not testing them they changed their name to PASS (Performer Availability Screening Services).

This may not seem to be much of anything but a name change, but it’s so much more.  It’s the FSC trying to cover their ass while putting yours at risk!  Yes, we have the latest and greatest tests on the market, as Diane Duke will tell you.  What she won’t tell you is that screening your blood is not the same as testing your blood for HIV.

The HIV 1 RNA Aptima tests is the best test on the market but it is NOT approved for use in screening blood.  So when they screen our blood (pool up to 100 samples together) in the adult industry, how safe is it?

FROM: http://www.aidsmap.com/Accuracy/page/1323304/

Accuracy

Although these tests have been used for the diagnosis of primary HIV infection, especially in the United States, they are not designed or approved by regulatory authorities for that purpose. False positive results are fairly common. A low level HIV RNA level (less than 5000 copies/ml) may be a false positive test result, because RNA levels during primary infection would normally be extremely high (above 100,000 copies/ml).

A CDC study assessed three NAAT tests against over 1100 samples of people who were either uninfected or had chronic infection. The sensitivities were somewhat low (indicating a reduced ability to correctly identify all HIV-positive samples) and varied according to the test used. The Roche Cobas Ampliscreen had a sensitivity of 92.6%, an in-house assay for RNA had a sensitivity of 95.8% and the Aptima qualitative assay had a sensitivity of 97.4%. Specificity was better, with scores of 96.9%, 99.4% and 99.6% respectively.1

Most tests only detect HIV-1 – very few are capable of detecting HIV-2.

When these tests are run on pooled samples, there have been case reports of false negative results, possibly due to a sample with a very low viral load being harder to detect when mixed with other, uninfected, samples.

FROM: www.fda.gov

The APTIMA® HIV-1 RNA Qualitative Assay is an in vitro nucleic acid assay system for the detection of human immunodeficiency virus (HIV-1) in human plasma. It is intended for use as an aid in the diagnosis of HIV-1 infection, including acute or primary infection. Presence of HIV-1 RNA in the plasma of patients without antibodies to HIV-1 is indicative of acute or primary HIV-1 infection.

The APTIMA HIV-1 RNA Qualitative Assay may also be used as an additional test, when it is reactive, to confirm HIV-1 infection in an individual whose specimen is repeatedly reactive for HIV-1 antibodies.

This assay is not intended for use in screening blood or plasma donors.

Speaking of plasma, what happens to our plasma when they spin it off in the centrifuge to screen our blood?  Do they pour it down the drain? Do they sell it?  I have not got a straight answer on this one!

Maybe we should stop being sheep and pick our heads up to notice what is going on around us…we are being led to slaughter!